Steadymed Ltd. (STDY) 10.10 $STDY
SteadyMed Granted Additional U.S. Patent With Patent Term Extension
GlobeNewswire - Wed Apr 22, 6:00AM CDT
SteadyMed Ltd. (Nasdaq:STDY) a specialty pharmaceutical company, today announced the issuance of a new patent from the United States Patent and Trademark Office (USPTO) and receipt of a Patent Term Extension. The patent provides additional intellectual property protection through June 2028 for SteadyMed's PatchPump platform technology, which is the drug administration system for its lead drug product candidate Trevyent, for the potential treatment of the orphan disease pulmonary arterial hypertension (PAH).
STDY: 10.10 (+0.11)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Apr 20, 11:47AM CDT
SPPR: 2.55 (-0.16), FNRG: 3.11 (-0.86), BIOC: 3.15 (+0.02), NVGN: 7.40 (-0.30), AMPE: 2.89 (+0.20), TRIL: 20.67 (-2.53), CZR: 9.68 (-0.24), TLOG: 4.70 (-0.21), BCLI: 4.29 (-0.09), STDY: 10.10 (+0.11), GENE: 4.88 (-0.05), FARO: 44.64 (-0.93), ICON: 27.06 (+0.45), XXII: 1.50 (+0.04), XBIT: 27.55 (+0.18), UEC: 2.12 (+0.29), COOL: 1.40 (-0.21), CALA: 12.93 (-1.06), WPCS: 3.71 (-0.17), VIMC: 13.42 (+1.31)
SteadyMed Appoints David W. Nassif as Its Full Time Executive Vice President and Chief Financial Officer
GlobeNewswire - Wed Apr 08, 6:30AM CDT
SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company, today announced the appointment of David W. Nassif as its full time Executive Vice President and Chief Financial Officer. In this capacity, Mr. Nassif will oversee the financial, SEC reporting, accounting, legal, investor relations and administrative functions of the company. He had been the company's Chief Financial Officer on a part-time consulting basis since March 2013.
STDY: 10.10 (+0.11)
InsiderInsights.com Daily Round Up 3/25/15: VNR, VNCE, HCOM, WIW
InsiderInsights - at Seeking Alpha - Thu Mar 26, 10:34AM CDT
STFC: 23.83 (-0.01), HCOM: 26.80 (+0.05), AIV: 38.63 (+0.70), SLG: 128.51 (+0.39), ZEN: 23.61 (-0.19), VNCE: 19.10 (-0.08), ABDC: 13.70 (-0.19), GOOG: 539.36 (+5.39), STDY: 10.10 (+0.11), PN: 14.26 (+0.02), WIW: 11.45 (unch), TJX: 66.41 (+0.12), PHII: 31.78 (+0.40), DYN: 33.28 (+0.24), ICPT: 280.45 (-8.26), RSPP: 28.20 (-0.04), ROST: 103.90 (+0.28), VNR: 15.85 (+0.04)
SteadyMed Announces Closing of Initial Public Offering
GlobeNewswire - Wed Mar 25, 1:26PM CDT
SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a price to the public of $8.50 per share, resulting in gross proceeds of approximately $40.0 million before underwriting discounts and commissions. All of the ordinary shares were offered by SteadyMed. The ordinary shares began trading on The NASDAQ Global Market under the ticker symbol "STDY" on March 20, 2015.
WFC: 54.67 (+0.39), STDY: 10.10 (+0.11)
U.S. IPO Weekly Recap: 2 Firms Go Public As A Birmingham Bank Bounds While Med-Tech Misses
Renaissance Capital IPO Research - at Seeking Alpha - Sat Mar 21, 7:00AM CDT
National Commerce raised $33 million and then the Birmingham bank bounded. Two small medical device companies struggled as SteadyMed had a shaky opening and another pushed its IPO to next week. IPO highlights during the week of March 16, 2015: ...
NCOM: 21.79 (-0.01), VLRX: (), BLPH: 9.98 (-0.08), STDY: 10.10 (+0.11)
SteadyMed drops price of IPO
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 6:38AM CDT
STDY: 10.10 (+0.11)
SteadyMed Announces Pricing of Initial Public Offering
GlobeNewswire - Fri Mar 20, 6:00AM CDT
SteadyMed Ltd., a specialty pharmaceutical company, today announced the pricing of its initial public offering of 4,700,000 ordinary shares at a price to the public of $8.50 per share. SteadyMed's ordinary shares are expected to begin trading on The NASDAQ Global Market under the symbol "STDY" on March 20, 2015. The offering is expected to close on March 25, 2015, subject to customary closing conditions. All of the ordinary shares are being offered by SteadyMed. In addition, SteadyMed has granted the underwriters a 30-day option to purchase up to an additional 705,000 ordinary shares.
WFC: 54.67 (+0.39), STDY: 10.10 (+0.11)
IPO Preview: SteadyMed
IPOdesktop - at Seeking Alpha - Thu Mar 19, 11:28PM CDT
Based in Rehovot, Israel, SteadyMed (Pending: STDY ) has scheduled a $56 million IPO on Nasdaq with a market capitalization of $160 million, at a price range midpoint of $13, for Friday, March 20, 2015. The full IPO calendar is available at ...
STDY: 10.10 (+0.11)
SteadyMed IPO Looks Shaky
Don Dion - at Seeking Alpha - Thu Mar 19, 6:29PM CDT
STDY: 10.10 (+0.11)
SteadyMed Could Pay Off Well For Early Investors
APBK Capital - at Seeking Alpha - Thu Mar 19, 11:45AM CDT
STDY: 10.10 (+0.11)
Week Ahead: 3 IPOs Planned For The Week Of March 16
Renaissance Capital IPO Research - Seeking Alpha - Mon Mar 16, 4:18PM CDT
Three IPOs are expected to price this week - a pump, a pump replacement and a regional bank - though the combined proceeds will still fall short of last week's single IPO . Get pumped for medical pumps SteadyMed (Pending: STDY ) is developing a...
SEDG: 23.81 (+0.13), PRTY: 20.65 (-0.22), TNDM: 13.84 (+0.07), UTHR: 187.98 (+0.12), VLRX: (), PUMP: (), BLPH: 9.98 (-0.08), STDY: 10.10 (+0.11)
SteadyMed Granted Additional U.S. Patent With Patent Term Extension
GlobeNewswire - Wed Apr 22, 6:00AM CDT
SteadyMed Ltd. (Nasdaq:STDY) a specialty pharmaceutical company, today announced the issuance of a new patent from the United States Patent and Trademark Office (USPTO) and receipt of a Patent Term Extension. The patent provides additional intellectual property protection through June 2028 for SteadyMed's PatchPump platform technology, which is the drug administration system for its lead drug product candidate Trevyent, for the potential treatment of the orphan disease pulmonary arterial hypertension (PAH).
STDY: 10.10 (+0.11)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Apr 20, 11:47AM CDT
SPPR: 2.55 (-0.16), FNRG: 3.11 (-0.86), BIOC: 3.15 (+0.02), NVGN: 7.40 (-0.30), AMPE: 2.89 (+0.20), TRIL: 20.67 (-2.53), CZR: 9.68 (-0.24), TLOG: 4.70 (-0.21), BCLI: 4.29 (-0.09), STDY: 10.10 (+0.11), GENE: 4.88 (-0.05), FARO: 44.64 (-0.93), ICON: 27.06 (+0.45), XXII: 1.50 (+0.04), XBIT: 27.55 (+0.18), UEC: 2.12 (+0.29), COOL: 1.40 (-0.21), CALA: 12.93 (-1.06), WPCS: 3.71 (-0.17), VIMC: 13.42 (+1.31)
SteadyMed Appoints David W. Nassif as Its Full Time Executive Vice President and Chief Financial Officer
GlobeNewswire - Wed Apr 08, 6:30AM CDT
SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company, today announced the appointment of David W. Nassif as its full time Executive Vice President and Chief Financial Officer. In this capacity, Mr. Nassif will oversee the financial, SEC reporting, accounting, legal, investor relations and administrative functions of the company. He had been the company's Chief Financial Officer on a part-time consulting basis since March 2013.
STDY: 10.10 (+0.11)
InsiderInsights.com Daily Round Up 3/25/15: VNR, VNCE, HCOM, WIW
InsiderInsights - at Seeking Alpha - Thu Mar 26, 10:34AM CDT
STFC: 23.83 (-0.01), HCOM: 26.80 (+0.05), AIV: 38.63 (+0.70), SLG: 128.51 (+0.39), ZEN: 23.61 (-0.19), VNCE: 19.10 (-0.08), ABDC: 13.70 (-0.19), GOOG: 539.36 (+5.39), STDY: 10.10 (+0.11), PN: 14.26 (+0.02), WIW: 11.45 (unch), TJX: 66.41 (+0.12), PHII: 31.78 (+0.40), DYN: 33.28 (+0.24), ICPT: 280.45 (-8.26), RSPP: 28.20 (-0.04), ROST: 103.90 (+0.28), VNR: 15.85 (+0.04)
SteadyMed Announces Closing of Initial Public Offering
GlobeNewswire - Wed Mar 25, 1:26PM CDT
SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a price to the public of $8.50 per share, resulting in gross proceeds of approximately $40.0 million before underwriting discounts and commissions. All of the ordinary shares were offered by SteadyMed. The ordinary shares began trading on The NASDAQ Global Market under the ticker symbol "STDY" on March 20, 2015.
WFC: 54.67 (+0.39), STDY: 10.10 (+0.11)
U.S. IPO Weekly Recap: 2 Firms Go Public As A Birmingham Bank Bounds While Med-Tech Misses
Renaissance Capital IPO Research - at Seeking Alpha - Sat Mar 21, 7:00AM CDT
National Commerce raised $33 million and then the Birmingham bank bounded. Two small medical device companies struggled as SteadyMed had a shaky opening and another pushed its IPO to next week. IPO highlights during the week of March 16, 2015: ...
NCOM: 21.79 (-0.01), VLRX: (), BLPH: 9.98 (-0.08), STDY: 10.10 (+0.11)
SteadyMed drops price of IPO
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 6:38AM CDT
STDY: 10.10 (+0.11)
SteadyMed Announces Pricing of Initial Public Offering
GlobeNewswire - Fri Mar 20, 6:00AM CDT
SteadyMed Ltd., a specialty pharmaceutical company, today announced the pricing of its initial public offering of 4,700,000 ordinary shares at a price to the public of $8.50 per share. SteadyMed's ordinary shares are expected to begin trading on The NASDAQ Global Market under the symbol "STDY" on March 20, 2015. The offering is expected to close on March 25, 2015, subject to customary closing conditions. All of the ordinary shares are being offered by SteadyMed. In addition, SteadyMed has granted the underwriters a 30-day option to purchase up to an additional 705,000 ordinary shares.
WFC: 54.67 (+0.39), STDY: 10.10 (+0.11)
IPO Preview: SteadyMed
IPOdesktop - at Seeking Alpha - Thu Mar 19, 11:28PM CDT
Based in Rehovot, Israel, SteadyMed (Pending: STDY ) has scheduled a $56 million IPO on Nasdaq with a market capitalization of $160 million, at a price range midpoint of $13, for Friday, March 20, 2015. The full IPO calendar is available at ...
STDY: 10.10 (+0.11)
SteadyMed IPO Looks Shaky
Don Dion - at Seeking Alpha - Thu Mar 19, 6:29PM CDT
STDY: 10.10 (+0.11)
SteadyMed Could Pay Off Well For Early Investors
APBK Capital - at Seeking Alpha - Thu Mar 19, 11:45AM CDT
STDY: 10.10 (+0.11)
Week Ahead: 3 IPOs Planned For The Week Of March 16
Renaissance Capital IPO Research - Seeking Alpha - Mon Mar 16, 4:18PM CDT
Three IPOs are expected to price this week - a pump, a pump replacement and a regional bank - though the combined proceeds will still fall short of last week's single IPO . Get pumped for medical pumps SteadyMed (Pending: STDY ) is developing a...
SEDG: 23.81 (+0.13), PRTY: 20.65 (-0.22), TNDM: 13.84 (+0.07), UTHR: 187.98 (+0.12), VLRX: (), PUMP: (), BLPH: 9.98 (-0.08), STDY: 10.10 (+0.11)
